Cargando…

Qualitative Immune Modulation by Interleukin-2 (IL-2) Adjuvant Therapy in Immunological Non Responder HIV-Infected Patients

BACKGROUND: Treatment of HIV-infected patients with interleukin-2 (IL-2) produces significant increases in CD4 T cell counts; however an associated qualitative improvement in cells function has yet to be conclusively demonstrated. By measuring mycobacterial killing activity, we evaluated IL-2-mediat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sabbatini, Francesca, Bandera, Alessandra, Ferrario, Giulio, Trabattoni, Daria, Marchetti, Giulia, Franzetti, Fabio, Clerici, Mario, Gori, Andrea
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2010
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2993926/ https://www.ncbi.nlm.nih.gov/pubmed/21124762 http://dx.doi.org/10.1371/journal.pone.0014119

Ejemplares similares

CD4+ T Cell Depletion, Immune Activation and Increased Production of Regulatory T Cells in the Thymus of HIV-Infected Individuals
por: Bandera, Alessandra, et al.
Publicado: (2010)

Fully Immunocompetent CD8+ T Lymphocytes Are Present in Autologous Haematopoietic Stem Cell Transplantation Recipients Despite an Ineffectual T-Helper Response
por: Bandera, Alessandra, et al.
Publicado: (2008)

Prospective Immune Dynamics during the First 24 Weeks of Efavirenz Based-Antiretroviral Therapy in HIV-1-Infected Subjects, According to CD4(+) T-Cell Counts at Presentation: The IMMUNEF Clinical Trial
por: Soria, Alessandro, et al.
Publicado: (2015)

Spoligotyping and Mycobacterium tuberculosis
por: Gori, Andrea, et al.
Publicado: (2005)

The NLRP3 Inflammasome Is Upregulated in HIV-Infected Antiretroviral Therapy-Treated Individuals with Defective Immune Recovery
por: Bandera, Alessandra, et al.
Publicado: (2018)

Neurocognitive Impairment in HIV-Infected Naïve Patients with Advanced Disease: The Role of Virus and Intrathecal Immune Activation
por: Airoldi, Monica, et al.
Publicado: (2012)

Increased Bone Marrow Interleukin-7 (IL-7)/IL-7R Levels but Reduced IL-7 Responsiveness in HIV-Positive Patients Lacking CD4+ Gain on Antiviral Therapy
por: Bellistrì, Giusi Maria, et al.
Publicado: (2010)

Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

Pregnant Women Develop a Specific Immunological Long-Lived Memory Against SARS-COV-2
por: Fenizia, Claudio, et al.
Publicado: (2022)

Pseudo-Mannosylated DC-SIGN Ligands as Potential Adjuvants for HIV Vaccines
por: Berzi, Angela, et al.
Publicado: (2014)

Immunological Characterization of HIV and SARS-CoV-2 Coinfected Young Individuals
por: Vanetti, Claudia, et al.
Publicado: (2021)

A Natural Immunological Adjuvant Enhances T Cell Clonal Expansion through a CD28-dependent, Interleukin (IL)-2–independent Mechanism
por: Khoruts, Alexander, et al.
Publicado: (1998)

KIR-HLA Genotypes in HIV-Infected Patients Lacking Immunological Recovery despite Effective Antiretroviral Therapy
por: Soria, Alessandro, et al.
Publicado: (2011)

Correction: Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
por: Rainone, Veronica, et al.
Publicado: (2016)

Antiretroviral compounds affect the granule-dependent mechanisms of lysis in CD8 T cells
por: Parmigiani, Anita, et al.
Publicado: (2006)

Interleukin 2 therapy in cancer: identification of responders.
por: Broom, J., et al.
Publicado: (1992)

Reduced natural killer cell activity and IL-2 production in malnourished cancer patients.
por: Villa, M. L., et al.
Publicado: (1991)

Recombinant interleukin-2 (rIL-2) with flavone acetic acid (FAA) in advanced malignant melanoma: immunological studies.
por: Ghosh, A. K., et al.
Publicado: (1990)

Interleukin-1 Stimulates β-Cell Necrosis and Release of the Immunological Adjuvant HMGB1
por: Steer, Sarah A, et al.
Publicado: (2006)

Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
por: Lombardi, Andrea, et al.
Publicado: (2022)

Cytotoxic T cells both produce and respond to interleukin 2
por: Andrus, L, et al.
Publicado: (1984)

Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine
por: Saresella, Marina, et al.
Publicado: (2022)

Pseudo-Mannosylated DC-SIGN Ligands as Immunomodulants
por: Berzi, Angela, et al.
Publicado: (2016)

Mini Review Immunological Consequences of Immunization With COVID-19 mRNA Vaccines: Preliminary Results
por: Lombardi, Andrea, et al.
Publicado: (2021)

The Immunological Profile of SARS-CoV-2 Infection in Children Is Linked to Clinical Severity and Age
por: Vanetti, Claudia, et al.
Publicado: (2023)

Intravenous ascorbic acid as an adjuvant to interleukin-2 immunotherapy
por: Wagner, Samuel C, et al.
Publicado: (2014)

Retinoids, breast cancer and NK cells.
por: Villa, M. L., et al.
Publicado: (1993)

Data on interleukin (IL)-2- and IL-15-dependent changes in IL-2Rβ and IL-2Rγ complexes
por: Osinalde, Nerea, et al.
Publicado: (2017)

IMMUNOLOGICAL ADJUVANTS AND THE MECHANISM OF CELL COOPERATION
por: Maillard, Jean, et al.
Publicado: (1972)

Maraviroc Reduces Arterial Stiffness in PI-Treated HIV-infected Patients
por: Piconi, Stefania, et al.
Publicado: (2016)

Production of Interleukin-2 (IL-2) and Expression of IL-2 Receptor in Patients with IgA Nephropathy
por: Lee, Tae-Won, et al.
Publicado: (1992)

Targeting IL-2: an unexpected effect in treating immunological diseases
por: Ye, Congxiu, et al.
Publicado: (2018)

Therapeutic Potential of the Gut Microbiota in the Management of Sepsis
por: Bassetti, Matteo, et al.
Publicado: (2020)

Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection
por: Saulle, Irma, et al.
Publicado: (2019)

Humoral and cell-mediated immune responses after a booster dose of HBV vaccine in HIV-infected children, adolescents and young adults
por: Giacomet, Vania, et al.
Publicado: (2018)

Corrigendum: Endoplasmic Reticulum Associated Aminopeptidase 2 (ERAP2) Is Released in the Secretome of Activated MDMs and Reduces in vitro HIV-1 Infection
por: Saulle, Irma, et al.
Publicado: (2019)

Evaluation of the Prognostic Value of Impaired Renal Function on Clinical Progression in a Large Cohort of HIV-Infected People Seen for Care in Italy
por: Bandera, Alessandra, et al.
Publicado: (2015)

Acute Human Immunodeficiency Virus (HIV) Infection Presenting With Bilateral Interstitial Pneumonia: Case Report and Discussion of Potential HIV-Induced Interstitial Pneumonia
por: Peri, Anna Maria, et al.
Publicado: (2017)

Immunologic hypo- or non-responder in natural dengue virus infection
por: Perng, Guey Chuen, et al.
Publicado: (2013)

Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact
por: Alì, G, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_geh351it4e2ld10708bv88av7g